Cobra Bio, Mayne Pharma Ltd., Commonwealth Scientific and Industrial Research Organization deal

CBF will manufacture sheep adenovirus for use in toxicology and Phase I/II trials of an adenoviral-based prostate cancer therapeutic from Mayne and CSIRO. Cobra has an option to supply adenovirus for ...